Moderna Inc. buy The Goldman Sachs Group, Inc.
Start price
28.01.25
/
50%
€41.85
Target price
28.01.26
€94.88
Performance (%)
-36.86%
Price
18.12.25
€26.43
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Moderna Inc. is performing very badly with a performance of -36.86%. This prediction currently runs until 28.01.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 4.716% | 4.716% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $112.00 to $99.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat